| Product Code: ETC6649974 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Antithrombotic Drugs Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Antithrombotic Drugs Market - Industry Life Cycle |
3.4 Canada Antithrombotic Drugs Market - Porter's Five Forces |
3.5 Canada Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Canada Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Canada Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Canada Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Canada Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Canada |
4.2.2 Growing awareness about antithrombotic drugs and their benefits |
4.2.3 Technological advancements leading to the development of novel antithrombotic drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 High costs associated with antithrombotic drug development and treatment |
4.3.3 Potential side effects and risks associated with antithrombotic drugs |
5 Canada Antithrombotic Drugs Market Trends |
6 Canada Antithrombotic Drugs Market, By Types |
6.1 Canada Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Canada Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 Canada Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 Canada Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 Canada Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 Canada Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 Canada Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 Canada Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Canada Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 Canada Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 Canada Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 Canada Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Canada Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 Canada Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 Canada Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 Canada Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 Canada Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Canada Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Canada Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Canada Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Canada Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Canada Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Canada Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Canada Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 Canada Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Canada Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Canada Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Canada Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Canada Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 Canada Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 Canada Antithrombotic Drugs Market Export to Major Countries |
7.2 Canada Antithrombotic Drugs Market Imports from Major Countries |
8 Canada Antithrombotic Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to antithrombotic drug therapy |
8.2 Number of clinical trials for new antithrombotic drugs in Canada |
8.3 Rate of adoption of novel antithrombotic drugs in the market |
8.4 Average length of hospital stay for patients receiving antithrombotic drug treatment |
9 Canada Antithrombotic Drugs Market - Opportunity Assessment |
9.1 Canada Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Canada Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Canada Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Canada Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Canada Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Antithrombotic Drugs Market - Competitive Landscape |
10.1 Canada Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Canada Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here